Harmony Biosciences Holdings, Inc. HRMY Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s free cash flow margin?
- Harmony Biosciences Holdings, Inc. (HRMY) reported free cash flow margin of 40.1% in Q4 2025.
- How has Harmony Biosciences Holdings, Inc.'s free cash flow margin changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s free cash flow margin increased by 30.9% year-over-year, from 30.6% to 40.1%.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s free cash flow margin?
- Over 4 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s free cash flow margin has grown at a 115.1% compound annual growth rate (CAGR), from -1.9% to 40.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.